Table 11.
Comparison of Estimated Annual Incidence of Visual Impairment and Blindness by United States and World Health Organization Criteria Stratified by Age in Barbadian Afro-Caribbeans and Los Angeles Latinos
Age at baseline (years) |
Visual impairment |
Blindness |
||||||
---|---|---|---|---|---|---|---|---|
LALES |
BISED |
LALES |
BISED |
|||||
N | % (CI) | N | % (CI) | N | % (CI) | N | % (CI) | |
United States Criterion* | ||||||||
40–49 | 1751 | 0.1 (0.0, 0.3) | 978 | 0.1 (0.0, 0.4) | 1754 | ‡ | 989 | ‡ |
50–59 | 1444 | 0.1 (0.0, 0.3) | 825 | 0.5 (0.0, 0.9) | 1446 | 0.1 (0.0, 0.2) | 847 | 0.1 (0.0, 0.2) |
60–69 | 913 | 0.4 (0.0, 0.8) | 658 | 1.7 (0.7, 2.7) | 931 | 0.1 (0.0, 0.3) | 721 | 0.3 (0.0, 0.7) |
70+ | 454 | 1.4 (0.3, 2.5) | 409 | 5.4 (3.2, 7.6) | 476 | 0.2 (0.0, 0.6) | 533 | 1.8 (0.7, 3.0) |
World Health Organization Criterion† | ||||||||
40–49 | 1751 | 0.03 (0.0, 0.1) | 986 | 0.1 (0.0, 0.2) | 1755 | ‡ | 989 | ‡ |
50–59 | 1444 | 0.1 (0.0, 0.2) | 832 | 0.3 (0.0, 0.7) | 1446 | 0.1 (0.0, 0.2) | 848 | ‡ |
60–69 | 922 | 0.3 (0.1, 0.7) | 703 | 1.0 (0.3, 1.8) | 932 | ‡ | 726 | 0.2 (0.0, 0.4) |
70+ | 468 | 0.9 (0.0, 1.7) | 472 | 3.6 (1.9, 5.2) | 481 | 0.2 (0.0, 0.5) | 549 | 0.7 (0.0, 1.4) |
LALES = Los Angeles Latino Eye Study, BISED = Barbados Incidence Study of Eye Diseases, WHO = World Health Organization.
N= number at risk for incidence of visual Impairment/blindness at baseline. % (CI)=prevalence and 95% confidence interval; estimated from overall 4-year incidence data for LALES and BISED studies.
US Criterion Incidence of Visual Impairment: Persons with Baseline BCVA 20/40 or better and follow-up BCVA worse than 20/40 but better than 20/200 (not including 20/40 or 20/200). Incidence of Blindness: Persons with Baseline BCVA better than 20/200 and follow-up BCVA 20/200 or worse (including 20/200).
W.H.O. Criterion. Incidence of Visual Impairment: Persons with Baseline BCVA 20/60 or better and follow-up BCVA worse than 20/60 but better than or equal to 20/400 (not including 20/60 but including 20/400). Incidence of Blindness: Persons with Baseline BCVA 20/400 or better and follow-up BCVA worse 20/400 (not including 20/400).
No incident cases.